The Safety and Efficacy of Risperidone as Adjunctive Therapy to Mood Stabilizers in the Long-term Treatment of Bipolar Mania

NCT00216554 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

118

Enrollment

INDUSTRY

Sponsor class

Conditions

Bipolar Disorder

Interventions

DRUG: risperidone

Sponsor

Janssen Korea, Ltd., Korea